AVRION THERAPEUTICS
Avrion Therapeutics is a precision Gene Therapies for Neurodegenerative Diseases.
AVRION THERAPEUTICS
Industry:
Biotechnology Therapeutics
Founded:
2020-01-01
Address:
Allschwil, Basel-Landschaft, Switzerland
Country:
Switzerland
Website Url:
http://www.avriontx.com
Total Employee:
1+
Status:
Active
Total Funding:
3 M CHF
Technology used in webpage:
Font Awesome U.S. Server Location
Similar Organizations
Alia Therapeutics
Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases.
B-SMART
B-SMART is an RNA-based therapy perspective for neurodegenerative diseases.
Lysosomal Therapeutics
Lysosomal Therapeutics deliver cures for neurodegenerative diseases.
Modis Therapeutics
Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.
NOGA Therapeutics
NOGA Therapeutics is a Developing Gene Therapies to Cure Primary Immune Deficiencies.
Current Employees Featured
Official Site Inspections
http://www.avriontx.com Semrush global rank: 11.88 M Semrush visits lastest month: 143
Unable to get host informations!!!
More informations about "Avrion Therapeutics"
about - Avrion Tx
Avrion Therapeutics was founded in 2020 based on 10+ years of research from the Brain Mind Institute and Bertarelli Foundation Gene Therapy Platform at EPFL - the Swiss Federal โฆSee details»
Avrion Therapeutics 2025 Company Profile: Valuation, โฆ
Avrion Therapeutics General Information Description. Developer of precision gene therapies designed for the treatment of neurological disorders. The โฆSee details»
Avrion Therapeutics AG - S-GE
Switzerland Global Enterprise is the official Swiss organization for export and investment promotion. As a private consulting and platform organization commissioned by the โฆSee details»
Avrion Therapeutics - Crunchbase Company Profile & Funding
Avrion Therapeutics is a precision Gene Therapies for Neurodegenerative Diseases.See details»
Avrion Therapeutics AG - Drug pipelines, Patents, Clinical trials
Explore Avrion Therapeutics AG with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Endocrinology and Metabolic Disease, Nervous System Diseases, โฆSee details»
Avrion Tx - Overview, News & Similar companies | ZoomInfo.com
View Avrion Tx (www.avriontx.com) location in Basel-Landschaft, Switzerland , revenue, industry and description. Find related and similar companies as well as employees by title and much โฆSee details»
Avrion Therapeutics - VentureRadar
"Avrion Therapeutics targets genetically-linked neurodegenerative diseases using precision gene therapy to enable long-term solutions. Avrion has developed a first-in-class precision gene โฆSee details»
home [www.avriontx.com]
Avrion Therapeutics precision gene therapies for neurodegeneration including motor neuron disease ALSSee details»
Avrion Therapeutics - Products, Competitors, Financials, โฆ
Avriontx.com. Overview & Products; Financials; People; Founded Year 2020. Stage Seed | Alive. Total Raised $1.11M. Last Raised $1.11M | 4 yrs ago. About Avrion Therapeutics. Avrion โฆSee details»
Avrion Therapeutics AG - startup.ch
Avrion Therapeutics AG: Avrion Therapeutics is a spin-off from EPFL developing precision gene therapy solutions to address genetically defined neurological disorders. Gene therapies can โฆSee details»
Avrion Therapeutics AG - Swiss Biotech
Spin-off from EPFL developing precision gene therapies for Amyotrophic Lateral Sclerosis (ALS). ALS pathogenic mechanisms support that non-neuronal cells play a key role in this disease, โฆSee details»
Avrion and Remedys are developing a single dose ALS therapy
Apr 27, 2023 We at Avrion, in collaboration with ReMedys, are performing Non-Human Primate (NHP) studies with our AAV (Adeno-Associated Virus) based Precision Gene Therapy โฆSee details»
Contact - Avrion Tx
Avrion Therapeutics SA 3DLegal Rue De Bourg 27 Lausanne VD 1003 Switzerland [email protected]See details»
BOARD - Avrion Tx
Dr. Kostas Kaloulis PhD - Board member and co-founder Kostas has more than 18 years of experience in the biopharmaceutical industry, with roles in business development, corporate โฆSee details»
Avrion Therapeutics - VentureRadar
Website: https://www.avriontx.com. Develops precision gene therapies for neurological disorders using AAV-based technology, designing cell-type specific vectors and identifying novel targets โฆSee details»
about - Avrion Tx
Avrion Therapeutics was founded in 2020 based on 10+ years of research from the Brain Mind Institute and Bertarelli Foundation Gene Therapy Platform at the Swiss Federal Institute of โฆSee details»
Science - avriontx.com
PRODUCT DEVELOPMENT. AVR-001: Avrion's first clinical candidate gene therapy product, AVR-001, is preparing to enter IND-enabling studies to treat patients with a form of the fatal โฆSee details»
AVRION Pay
We deliver innovative technology that enables merchants to buy and sell online. The AVRION Pay payment is a server-based software providing secure and user-friendly payment processing โฆSee details»
Avrion Therapeutics AG (Avrion Therapeutics AG) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ โฆ
May 7, 2025 ไบ่งฃAvrion Therapeutics AG (Avrion Therapeutics AG)ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็๏ผ็พ็ ้ขๅ:็ฅ็ป็ณป็ป็พ็ ๏ผๅ ๅๆณไธไปฃ่ฐข็พ็ ๏ผๆๆฏๅนณๅฐ:ๅบๅ ็ๆณ๏ผ โฆSee details»
partners - Avrion Tx
Avrion Therapeutics precision gene therapies for neurodegeneration including motor neuron disease ALSSee details»